[ Price : $8.95]
Federal Register Notice: FDA plans a meeting 9/15 of the National Mammography Quality Assurance Advisory Committee to discuss comp...[ Price : $8.95]
AbbVie files suit against Amgen to block its biosimilar version of AbbVies blockbuster arthritis therapy Humira.[ Price : $8.95]
FDA accepts a Merck NDA for MK-1293, an investigational follow-on biologic copy of Sanofi-Aventis Lantus (insulin glargine) for us...[ Price : $8.95]
Bristol-Myers Squibb reports disappointing data from its CheckMate-026, a trial investigating the use of Opdivo (nivolumab) as mon...[ Price : $8.95]
FDA and Amarin agree to amend the companys special protocol assessment agreement for the REDUCE-IT cardiovascular outcomes study i...[ Price : $8.95]
Hogan Lovells attorneys say a new FDA draft guidance indicates the agencys willingness to consider using real-world evidence and d...[ Price : $8.95]
BIO publishes four bioethical considerations to focus its advocacy around truthful and non-misleading product communication.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on a national direct-to-consumer survey to the Office of...